{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:28:45Z","timestamp":1793838525774,"version":"4.6.1"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001026-00"],"award-info":[{"award-number":["MOH-001026-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CG21APR1017"],"award-info":[{"award-number":["CG21APR1017"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306433\/2023-0"],"award-info":[{"award-number":["306433\/2023-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306073\/2020-0"],"award-info":[{"award-number":["306073\/2020-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","award":["88887.839557\/2023-00"],"award-info":[{"award-number":["88887.839557\/2023-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bcp.2025.116908","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T12:30:18Z","timestamp":1743251418000},"page":"116908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Understanding the peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) role in periodontitis and diabetes mellitus: A molecular perspective"],"prefix":"10.1016","volume":"237","author":[{"given":"Ingra Gagno","family":"Nicchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamiris","family":"Cirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas C\u00e9sar da Costa","family":"Quil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Constantino","family":"Camilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Mantuaneli","family":"Scarel-Caminaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Renato Manzolli","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bcp.2025.116908_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081135","article-title":"Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues","volume":"8","author":"Kononen","year":"2019","journal-title":"J. Clin. Med."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2025.116908_b0010","first-page":"S173","article-title":"Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions","volume":"89","author":"Papapanou","year":"2018","journal-title":"J. Periodontol."},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1902\/jop.2015.140520","article-title":"Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012","volume":"86","author":"Eke","year":"2015","journal-title":"J. Periodontol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0020","first-page":"161","article-title":"The 4th National Oral Health Survey in the Mainland of China: Background and Methodology","volume":"21","author":"Lu","year":"2018","journal-title":"Chin. J. Dent. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jcpe.13565","article-title":"Cytokine profiles and the dynamic of gingivitis development in humans","volume":"49","author":"Leite","year":"2022","journal-title":"J. Clin. Periodontol."},{"issue":"11","key":"10.1016\/j.bcp.2025.116908_b0030","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/jcpe.13358","article-title":"Salivary proteotypes of gingivitis tolerance and resilience","volume":"47","author":"Bostanci","year":"2020","journal-title":"J. Clin. Periodontol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jcpe.13046","article-title":"An appraisal of the role of specific bacteria in the initial pathogenesis of periodontitis","volume":"46","author":"Bartold","year":"2019","journal-title":"J. Clin. Periodontol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/omi.12065","article-title":"The inflammophilic character of the periodontitis-associated microbiota","volume":"29","author":"Hajishengallis","year":"2014","journal-title":"Mol. Oral Microbiol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0040-1712718","article-title":"Cytokines and Chemokines in Periodontitis","volume":"14","author":"Ramadan","year":"2020","journal-title":"Eur J Dent"},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210290","article-title":"JAK\/STAT as a Potential Therapeutic Target for Osteolytic Diseases","volume":"24","author":"Godoi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/prd.12297","article-title":"The role of inflammation and genetics in periodontal disease","volume":"83","author":"Loos","year":"2000","journal-title":"Periodontology"},{"key":"10.1016\/j.bcp.2025.116908_b0060","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.1038\/nrdp.2017.38","article-title":"Periodontal diseases","volume":"3","author":"Kinane","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"45","key":"10.1016\/j.bcp.2025.116908_b0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0757.2007.00220.x","article-title":"Human variability in innate immunity","volume":"2000","author":"Kinane","year":"2007","journal-title":"Periodontol"},{"issue":"11","key":"10.1016\/j.bcp.2025.116908_b0070","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.tem.2016.06.008","article-title":"The Emerging Role of Epigenetics in Inflammation and Immunometabolism","volume":"27","author":"Raghuraman","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.bcp.2025.116908_b0075","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic modifications: basic mechanisms and role in cardiovascular disease","volume":"123","author":"Handy","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1159\/000457944","article-title":"Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases","volume":"41","author":"Wang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/cmi.2017.133","article-title":"Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity","volume":"15","author":"Wu","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13072-019-0279-4","article-title":"Human monocyte-to-macrophage differentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites","volume":"12","author":"Dekkers","year":"2019","journal-title":"Epigenetics Chromatin"},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrg3142","article-title":"Epigenetics and the environment: emerging patterns and implications","volume":"13","author":"Feil","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bcp.2025.116908_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.152667","article-title":"Content of toxic components of cigarette, cigarette smoke vs cigarette butts: A comprehensive systematic review","volume":"813","author":"Soleimani","year":"2022","journal-title":"Sci. Total Environ."},{"issue":"8","key":"10.1016\/j.bcp.2025.116908_b0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.crohns.2014.02.002","article-title":"Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect","volume":"8","author":"Parkes","year":"2014","journal-title":"J. Crohns Colitis"},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0110","doi-asserted-by":"crossref","first-page":"22279","DOI":"10.3390\/ijms151222279","article-title":"Smoking and rheumatoid arthritis","volume":"15","author":"Chang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.116908_b0115","first-page":"1","article-title":"The contribution of dietary composition over 25 years to cardiovascular risk factors in childhood and adulthood: the Princeton Lipid Research Study","author":"Beck","year":"2024","journal-title":"Br. J. Nutr."},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b0120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1047-2797(00)00065-X","article-title":"A comparison between BMI and Conicity index on predicting coronary heart disease: the Framingham Heart Study","volume":"10","author":"Kim","year":"2000","journal-title":"Ann. Epidemiol."},{"issue":"7181","key":"10.1016\/j.bcp.2025.116908_b0125","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature06796","article-title":"Translating molecular discoveries into new therapies for atherosclerosis","volume":"451","author":"Rader","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12903-023-03668-7","article-title":"Exploring the bi-directional relationship between periodontitis and dyslipidemia: a comprehensive systematic review and meta-analysis","volume":"24","author":"Ma","year":"2024","journal-title":"BMC Oral Health"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0135","doi-asserted-by":"crossref","DOI":"10.1177\/1759091414568185","article-title":"Nutrition facts in multiple sclerosis","volume":"7","author":"Riccio","year":"2015","journal-title":"ASN Neuro"},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1902\/jop.1991.62.5.293","article-title":"Periodontal findings in adult twins","volume":"62","author":"Michalowicz","year":"1991","journal-title":"J. Periodontol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b0145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cden.2015.06.005","article-title":"What is the Contribution of Genetics to Periodontal Risk?","volume":"59","author":"Loos","year":"2015","journal-title":"Dent. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/prd.12322","article-title":"Epigenetic reprogramming in periodontal disease: Dynamic crosstalk with potential impact in oncogenesis","volume":"82","author":"Barros","year":"2000","journal-title":"Periodontol"},{"issue":"6676","key":"10.1016\/j.bcp.2025.116908_b0155","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.298.6676.779","article-title":"Association between dental health and acute myocardial infarction","volume":"298","author":"Mattila","year":"1989","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0160","first-page":"72","article-title":"Prevalence of periodontal disease, its association with systemic diseases and prevention","volume":"11","author":"Nazir","year":"2017","journal-title":"Int J Health Sci (qassim)"},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0165","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","article-title":"Epigenetics in Human Obesity and Type 2 Diabetes","volume":"29","author":"Ling","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.116908_b0170","doi-asserted-by":"crossref","unstructured":"G.J. Linden, M.C. Herzberg, E.F.P.A.A.P.w. working group 4 of the joint, Periodontitis and systemic diseases: a record of discussions of working group 4 of the Joint EFP\/AAP Workshop on Periodontitis and Systemic Diseases, J. Periodontol. 84(4 Suppl) (2013) S20-3.","DOI":"10.1902\/jop.2013.1340020"},{"issue":"11","key":"10.1016\/j.bcp.2025.116908_b0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41415-019-1050-8","article-title":"Systemic disease or periodontal disease? Distinguishing causes of gingival inflammation: a guide for dental practitioners. Part 1: immune-mediated, autoinflammatory, and hereditary lesions","volume":"227","author":"Hirschfeld","year":"2019","journal-title":"Br. Dent. J."},{"issue":"Suppl 6","key":"10.1016\/j.bcp.2025.116908_b0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-051X.2005.00806.x","article-title":"Identification of genetic risk factors for periodontitis and possible mechanisms of action","volume":"32","author":"Loos","year":"2005","journal-title":"J. Clin. Periodontol."},{"issue":"8","key":"10.1016\/j.bcp.2025.116908_b0185","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/jdi.13477","article-title":"Epigenetic changes caused by diabetes and their potential role in the development of periodontitis","volume":"12","author":"Li","year":"2021","journal-title":"J Diabetes Investig"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41368-023-00227-2","article-title":"Periodontitis as a promoting factor of T2D: current evidence and mechanisms","volume":"15","author":"Su","year":"2023","journal-title":"Int. J. Oral Sci."},{"issue":"21","key":"10.1016\/j.bcp.2025.116908_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/nu15214671","article-title":"Regulation of Macronutrients in Insulin Resistance and Glucose Homeostasis during Type 2 Diabetes Mellitus","volume":"15","author":"Yang","year":"2023","journal-title":"Nutrients"},{"issue":"10085","key":"10.1016\/j.bcp.2025.116908_b0200","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","article-title":"Type 2 diabetes","volume":"389","author":"Chatterjee","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0205","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbadis.2017.01.016","article-title":"Dynamics of diabetes and obesity: Epidemiological perspective","volume":"1863","author":"Boles","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2337\/diabetes.51.1.144","article-title":"Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion","volume":"51","author":"Greco","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00592-013-0543-1","article-title":"The inflammatory status score including IL-6, TNF-alpha, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus","volume":"51","author":"Daniele","year":"2014","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.bcp.2025.116908_b0220","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes","volume":"10","author":"Zatterale","year":"2019","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b0225","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.bcp.2025.116908_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of Type 2 Diabetes Mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2025.116908_b0240","doi-asserted-by":"crossref","unstructured":"J.I. Barzilay, C.F. Spiekerman, L.H. Kuller, G.L. Burke, V. Bittner, J.S. Gottdiener, F.L. Brancati, T.J. Orchard, D.H. O'Leary, P.J. Savage, S. Cardiovascular Health, Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study, Diabetes Care 24(7) (2001) 1233-9.","DOI":"10.2337\/diacare.24.7.1233"},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0245","first-page":"150","article-title":"Dyslipidemia in type 2 diabetes mellitus","volume":"5","author":"Mooradian","year":"2009","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ecl.2013.09.005","article-title":"Type 2 diabetes mellitus and hypertension: an update","volume":"43","author":"Lastra","year":"2014","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b0255","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.HYP.37.4.1053","article-title":"Diabetes, hypertension, and cardiovascular disease: an update","volume":"37","author":"Sowers","year":"2001","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.bcp.2025.116908_b0260","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/00220345231179897","article-title":"Co-occurrence of Periodontitis and Diabetes-Related Complications","volume":"102","author":"Bitencourt","year":"2023","journal-title":"J. Dent. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00441-008-0685-6","article-title":"Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity","volume":"335","author":"Bakker","year":"2009","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0270","first-page":"329","article-title":"Periodontal disease","volume":"16","author":"Loe","year":"1993","journal-title":"The Sixth Complication of Diabetes Mellitus, Diabetes Care"},{"key":"10.1016\/j.bcp.2025.116908_b0275","article-title":"Polymorphisms in Genes of Lipid Metabolism Are Associated with Type 2 Diabetes Mellitus and Periodontitis, as Comorbidities, and with the Subjects' Periodontal","volume":"2021","author":"Nicchio","year":"2021","journal-title":"Glycemic, and Lipid Profiles, J Diabetes Res"},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b0280","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00592-018-1120-4","article-title":"Does diabetes increase the risk of periodontitis? A Systematic Review and Meta-Regression Analysis of Longitudinal Prospective Studies","volume":"55","author":"Nascimento","year":"2018","journal-title":"Acta Diabetol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0285","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/prd.12318","article-title":"The impact of diabetes on periodontal diseases","volume":"82","author":"Graves","year":"2000","journal-title":"Periodontol"},{"issue":"44","key":"10.1016\/j.bcp.2025.116908_b0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0757.2006.00193.x","article-title":"Diabetes mellitus and periodontal disease","volume":"2000","author":"Mealey","year":"2007","journal-title":"Periodontol"},{"issue":"11","key":"10.1016\/j.bcp.2025.116908_b0295","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s13300-020-00933-8","article-title":"Periodontal Disease in Diabetes Mellitus: A Case-Control Study in Smokers and Non-Smokers","volume":"11","author":"Battancs","year":"2020","journal-title":"Diabetes Ther"},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0300","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1007\/s00784-019-02888-y","article-title":"Prevalence of undiagnosed diabetes and pre-diabetes in chronic periodontitis patients assessed by an HbA1c chairside screening protocol","volume":"23","author":"Mataftsi","year":"2019","journal-title":"Clin. Oral Invest."},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b0305","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41415-019-0794-5","article-title":"Periodontitis and diabetes","volume":"227","author":"Preshaw","year":"2019","journal-title":"Br. Dent. J."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0310","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s40200-021-00861-9","article-title":"Association of hyperglycaemia and periodontitis: an updated systematic review and meta-analysis","volume":"20","author":"Mirzaei","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/prd.12235","article-title":"Periodontal complications of hyperglycemia\/diabetes mellitus: Epidemiologic complexity and clinical challenge","volume":"78","author":"Kocher","year":"2000","journal-title":"Periodontology"},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0320","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1902\/jop.1997.68.2.127","article-title":"Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients","volume":"68","author":"Salvi","year":"1997","journal-title":"J. Periodontol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b0325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.dsx.2016.12.007","article-title":"Cytokine ratios in chronic periodontitis and type 2 diabetes mellitus","volume":"11","author":"Acharya","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"issue":"Suppl 14","key":"10.1016\/j.bcp.2025.116908_b0330","first-page":"S113","article-title":"A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes","volume":"40","author":"Taylor","year":"2013","journal-title":"J. Clin. Periodontol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0335","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/prd.12298","article-title":"Diabetes as a risk factor for periodontal disease-plausible mechanisms","volume":"83","author":"Polak","year":"2000","journal-title":"Periodontology"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jcpe.12179","article-title":"Local levels of inflammatory mediators in uncontrolled type 2 diabetic subjects with chronic periodontitis","volume":"41","author":"Duarte","year":"2014","journal-title":"J. Clin. Periodontol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0345","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5051\/jpis.2011.41.3.109","article-title":"The influence of type 2 diabetes mellitus on the expression of inflammatory mediators and tissue inhibitor of metalloproteinases-2 in human chronic periodontitis","volume":"41","author":"Kim","year":"2011","journal-title":"J Periodontal Implant Sci"},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0350","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/0022034518805984","article-title":"Induction of M2 Macrophages Prevents Bone Loss in Murine Periodontitis Models","volume":"98","author":"Zhuang","year":"2019","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bcp.2025.116908_b0355","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/754802","article-title":"Abnormal cell responses and role of TNF-alpha in impaired diabetic wound healing","volume":"2013","author":"Xu","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2025.116908_b0360","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061738","article-title":"Functional Regulation of PPARs through Post-Translational Modifications","volume":"19","author":"Brunmeir","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0370","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPARgamma","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bcp.2025.116908_b0375","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbalip.2007.01.008","article-title":"Transcription coactivators for peroxisome proliferator-activated receptors","volume":"1771","author":"Yu","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2025.116908_b0380","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","article-title":"PPARgamma as a therapeutic target to rescue mitochondrial function in neurological disease","volume":"100","author":"Corona","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"17","key":"10.1016\/j.bcp.2025.116908_b0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179708","article-title":"The Role of Transcription Factor PPAR-gamma in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells","volume":"23","author":"Sobolev","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0390","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.55.01.06.db05-1077","article-title":"Adiponectin Does Not Cross the Blood-Brain Barrier but Modifies Cytokine Expression of Brain Endothelial Cells","volume":"55","author":"Spranger","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0395","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-006-0577-9","article-title":"Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum","volume":"50","author":"Kusminski","year":"2007","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1389557521666210422112740","article-title":"Peroxisome Proliferator-activated Receptor-gamma As A Novel and Promising Target For Treating Cancer Via Regulation of Inflammation: A Brief Review","volume":"22","author":"Yuvaraj","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b0405","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1006\/geno.2002.6748","article-title":"Guidelines for human gene nomenclature","volume":"79","author":"Wain","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.bcp.2025.116908_b0410","unstructured":"GeneCards, PPARG Gene - Peroxisome Proliferator-Activated Receptor Gamma, 2023. https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=PPARG&keywords=pparg#function. (Accessed 27\/10\/2023)."},{"issue":"4\u20135","key":"10.1016\/j.bcp.2025.116908_b0415","first-page":"281","article-title":"Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping","volume":"4","author":"Greene","year":"1995","journal-title":"Gene Expr."},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00005-008-0037-y","article-title":"Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma","volume":"56","author":"Zieleniak","year":"2008","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.bcp.2025.116908_b0425","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2015.11.004","article-title":"Fatty acids, eicosanoids and PPAR gamma","volume":"785","author":"Marion-Letellier","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116908_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.677130","article-title":"Genetics and Clinical Characteristics of PPARgamma Variant-Induced Diabetes in a Chinese Han Population","volume":"12","author":"Gong","year":"2021","journal-title":"Front Endocrinol (lausanne)"},{"key":"10.1016\/j.bcp.2025.116908_b0435","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/367450","article-title":"Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer","volume":"2012","author":"Stravodimou","year":"2012","journal-title":"PPAR Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405008793","article-title":"PPAR gamma as a metabolic regulator: insights from genomics and pharmacology","volume":"7","author":"Savage","year":"2005","journal-title":"Expert Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0445","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(03)00269-1","article-title":"Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity","volume":"113","author":"Wang","year":"2003","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0450","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b0455","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1101\/gad.1263305","article-title":"Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes","volume":"19","author":"Guan","year":"2005","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b0460","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1080\/07391102.2020.1835724","article-title":"Computational analysis of single nucleotide polymorphisms (SNPs) in PPAR gamma associated with obesity, diabetes and cancer","volume":"40","author":"Stalin","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.bcp.2025.116908_b0465","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.2337\/diabetes.54.10.3043","article-title":"Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women","volume":"54","author":"Meirhaeghe","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2025.116908_b0470","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5284867","article-title":"PPARG Polymorphisms Are Associated with Unexplained Mild Vision Loss in Patients with Type 2 Diabetes Mellitus","volume":"2019","author":"Li","year":"2019","journal-title":"J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0475","first-page":"3138","article-title":"PPARG, AGTR1, CXCL16 and LGALS2 polymorphisms are correlated with the risk for coronary heart disease","volume":"8","author":"Tian","year":"2015","journal-title":"Int. J. Clin. Exp. Path."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0480","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12872-024-03912-0","article-title":"Genetic markers of cardiac autonomic neuropathy in the Kazakh population","volume":"24","author":"Bekenova","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2025.116908_b0485","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000514506","article-title":"Role of Metabolic Risk Factors, Family History, and Genetic Polymorphisms (PPARgamma and TCF7L2) on Type 2 Diabetes Mellitus Risk in an Asian Indian Population","volume":"24","author":"Chaudhuri","year":"2021","journal-title":"Public Health Genomics"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0490","doi-asserted-by":"crossref","first-page":"55","DOI":"10.15605\/jafes.037.S5","article-title":"Validation of Genome-Wide Association Studies (GWAS)-Identified Type 2 Diabetes Mellitus Risk Variants in Pakistani Pashtun Population","volume":"38","author":"Jan","year":"2023","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0495","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000527520","article-title":"Cardiovascular Risk Factors in Children and Adolescents with Type 1 Diabetes Mellitus: The Role of Insulin Resistance and Associated Genetic Variants","volume":"96","author":"Maguolo","year":"2023","journal-title":"Horm. Res. Paediatr."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0500","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4183\/aeb.2022.139","article-title":"ASSOCIATION BETWEEN PRO12ALa POLYMORPHISM OF PPARgamma2 GENE AND CORONARY ARTERY DISEASE IN IRANIAN POPULATION WITH TYPE TWO DIABETES MELLITUS","volume":"18","author":"Saremi","year":"2022","journal-title":"Acta Endocrinol (buchar)"},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0505","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.diabres.2012.03.012","article-title":"Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population","volume":"97","author":"Ho","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0510","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/aps.2012.144","article-title":"PPAR-gamma2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China","volume":"34","author":"Pei","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2025.116908_b0515","doi-asserted-by":"crossref","unstructured":"N. Sarhangi, F. Sharifi, L. Hashemian, M. Hassani Doabsari, K. Heshmatzad, M. Rahbaran, S.H. Jamaldini, H.R. Aghaei Meybodi, M. Hasanzad, PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis, Sci Rep 10(1) (2020) 12764.","DOI":"10.1038\/s41598-020-69363-7"},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0520","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1902\/jop.2010.090669","article-title":"Peroxisome proliferator-activated receptor gamma polymorphism and periodontitis in pregnant Japanese women","volume":"81","author":"Hirano","year":"2010","journal-title":"J. Periodontol."},{"issue":"8","key":"10.1016\/j.bcp.2025.116908_b0525","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1902\/jop.2015.140472","article-title":"The Interaction Between beta-3 Adrenergic Receptor and Peroxisome Proliferator-Activated Receptor Gamma Gene Polymorphism to Periodontal Disease in Community-Dwelling Elderly Japanese","volume":"86","author":"Yoshihara","year":"2015","journal-title":"J. Periodontol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0530","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/ger.12110","article-title":"PPARgamma gene polymorphism, C-reactive protein level, BMI and periodontitis in post-menopausal Japanese women","volume":"33","author":"Wang","year":"2016","journal-title":"Gerodontology"},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b0535","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071438","article-title":"Influence of the Periodontal Disease, the Most Prevalent Inflammatory Event, in Peroxisome Proliferator-Activated Receptors Linking Nutrition and Energy Metabolism","volume":"18","author":"Roman-Malo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0540","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1753425910392089","article-title":"Variants of the human PPARG locus and the susceptibility to chronic periodontitis","volume":"17","author":"Folwaczny","year":"2011","journal-title":"Innate Immun."},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b0545","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076760","article-title":"Evidence Linking PPARG Genetic Variants with Periodontitis and Type 2 Diabetes Mellitus in a Brazilian Population","volume":"24","author":"Cirelli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0550","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/mend.11.6.0007","article-title":"Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay","volume":"11","author":"Krey","year":"1997","journal-title":"Mol. Endocrinol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b0555","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.116908_b0560","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/705352","article-title":"Emerging PPARgamma-Independent Role of PPARgamma Ligands in Lung Diseases","volume":"2012","author":"Kulkarni","year":"2012","journal-title":"PPAR Res."},{"issue":"7305","key":"10.1016\/j.bcp.2025.116908_b0565","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","article-title":"Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5","volume":"466","author":"Choi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.116908_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101363","article-title":"A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice","volume":"54","author":"Wu","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bcp.2025.116908_b0575","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/816856","article-title":"Review of the Structural and Dynamic Mechanisms of PPARgamma Partial Agonism","volume":"2015","author":"Kroker","year":"2015","journal-title":"PPAR Res."},{"issue":"52","key":"10.1016\/j.bcp.2025.116908_b0580","doi-asserted-by":"crossref","first-page":"40409","DOI":"10.1074\/jbc.R110.182451","article-title":"Endogenous ligands for nuclear receptors: digging deeper","volume":"285","author":"Schupp","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116908_b0585","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front Biosci"},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0590","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11892-019-1270-y","article-title":"Thiazolidinediones: the Forgotten Diabetes Medications","volume":"19","author":"Lebovitz","year":"2019","journal-title":"Curr. Diab. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0595","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","article-title":"Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): a review","volume":"92","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2025.116908_b0600","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","article-title":"Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta","volume":"94","author":"Forman","year":"1997","journal-title":"PNAS"},{"issue":"41","key":"10.1016\/j.bcp.2025.116908_b0605","doi-asserted-by":"crossref","first-page":"25500","DOI":"10.1074\/jbc.272.41.25500","article-title":"Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor","volume":"272","author":"Zhu","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0610","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0615","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0165-6147(00)01559-5","article-title":"PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer","volume":"21","author":"Murphy","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.116908_b0620","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/549691","article-title":"PPARgamma and the Innate Immune System Mediate the Resolution of Inflammation","volume":"2015","author":"Croasdell","year":"2015","journal-title":"PPAR Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0625","doi-asserted-by":"crossref","DOI":"10.3390\/md17060321","article-title":"An Algal Metabolite-Based PPAR-gamma Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-kappaB Pathway","volume":"17","author":"Ju","year":"2019","journal-title":"Mar. Drugs"},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0630","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1074\/jbc.272.2.971","article-title":"Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction","volume":"272","author":"Stephens","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0635","first-page":"1595","article-title":"Banting lecture 1988","volume":"37","author":"Reaven","year":"1988","journal-title":"Role of Insulin Resistance in Human Disease, Diabetes"},{"key":"10.1016\/j.bcp.2025.116908_b0640","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1475-2840-9-67","article-title":"The beneficial effects of exercise in rodents are preserved after detraining: a phenomenon unrelated to GLUT4 expression","volume":"9","author":"Lehnen","year":"2010","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6107(03)00055-5","article-title":"Effect of insulin and contraction up on glucose transport in skeletal muscle","volume":"84","author":"Pereira","year":"2004","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.116908_b0650","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/818945","article-title":"Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity","volume":"2009","author":"Leonardini","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.bcp.2025.116908_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114244","article-title":"Targeting PI3K\/AKT signaling pathway in obesity","volume":"159","author":"Savova","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0660","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.bbamcr.2015.09.009","article-title":"Regulation of insulin signaling in skeletal muscle by PIP3 phosphatase, SKIP, and endoplasmic reticulum molecular chaperone glucose-regulated protein 78","volume":"1853","author":"Ijuin","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0665","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0670","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.bcp.2025.116908_b0675","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0680","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm849","article-title":"The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion","volume":"9","author":"Chen","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2025.116908_b0685","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b0690","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2025.116908_b0695","doi-asserted-by":"crossref","unstructured":"F. Blaschke, E. Caglayan, W.A. Hsueh, Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes, Endocrinol Metab Clin North Am 35(3) (2006) 561-74, ix.","DOI":"10.1016\/j.ecl.2006.06.001"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2025.116908_b0700","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.33549\/physiolres.933439","article-title":"The role of PPARgamma in cardiovascular diseases","volume":"65","author":"Kvandova","year":"2016","journal-title":"Physiol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0705","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diabetes.51.1.30","article-title":"Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects","volume":"51","author":"Ciaraldi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2025.116908_b0710","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.nutr.22.010402.102808","article-title":"PPAR(gamma) and glucose homeostasis","volume":"22","author":"Picard","year":"2002","journal-title":"Annu. Rev. Nutr."},{"issue":"11","key":"10.1016\/j.bcp.2025.116908_b0715","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"18","key":"10.1016\/j.bcp.2025.116908_b0720","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.18632\/aging.102263","article-title":"MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-gamma-mediated PI3K\/AKT signaling","volume":"11","author":"Chen","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0725","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1248\/bpb.b14-00037","article-title":"Search for new type of PPARgamma agonist-like anti-diabetic compounds from medicinal plants","volume":"37","author":"Matsuda","year":"2014","journal-title":"Biol. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.bcp.2025.116908_b0730","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/db24-0008","article-title":"Regulation of STAT1 Signaling in Human Pancreatic beta-Cells by the Lysine Deacetylase HDAC6: A New Therapeutic Opportunity in Type 1 Diabetes?","volume":"73","author":"Leslie","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2025.116908_b0735","doi-asserted-by":"crossref","unstructured":"S. Theurich, E. Tsaousidou, R. Hanssen, A.M. Lempradl, J. Mauer, K. Timper, K. Schilbach, K. Folz-Donahue, C. Heilinger, V. Sexl, J.A. Pospisilik, F.T. Wunderlich, J.C. Bruning, IL-6\/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis, Cell Metab. 26(1) (2017) 171-184 e6.","DOI":"10.1016\/j.cmet.2017.05.018"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0740","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1038\/s41467-022-31126-5","article-title":"Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR\/STAT3\/IL-6 signaling","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0745","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/s41467-023-37831-z","article-title":"Glucocorticoid activation of anti-inflammatory macrophages protects against insulin resistance","volume":"14","author":"Caratti","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.116908_b0750","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2960517","article-title":"TLR4\/AP-1-Targeted Anti-Inflammatory Intervention Attenuates Insulin Sensitivity and Liver Steatosis","volume":"2020","author":"Hu","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bcp.2025.116908_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154936","article-title":"Sodium\/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts","volume":"127","author":"Marfella","year":"2022","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0760","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00125-014-3438-y","article-title":"Genetic deletion of Wdr13 improves the metabolic phenotype of Lepr (db\/db) mice by modulating AP1 and PPARgamma target genes","volume":"58","author":"Singh","year":"2015","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0765","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1210\/endo.143.5.8812","article-title":"Cbl, IRS-1, and IRS-2 mediate effects of rosiglitazone on PI3K, PKC-lambda, and glucose transport in 3T3\/L1 adipocytes","volume":"143","author":"Standaert","year":"2002","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0770","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate","volume":"108","author":"Kim","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bcp.2025.116908_b0775","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/diabetes.52.11.2784","article-title":"Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice","volume":"52","author":"Klover","year":"2003","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0780","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/endo.130.1.1727716","article-title":"Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output","volume":"130","author":"Lang","year":"1992","journal-title":"Endocrinology"},{"issue":"32","key":"10.1016\/j.bcp.2025.116908_b0785","doi-asserted-by":"crossref","first-page":"21839","DOI":"10.1016\/S0021-9258(18)54714-1","article-title":"Transcriptional repression of the GLUT4 and C\/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha","volume":"266","author":"Stephens","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116908_b0790","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther 2"},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0795","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0090-1229(90)90094-7","article-title":"Tumor necrosis factor in the pathophysiology of infection and sepsis","volume":"55","author":"Fong","year":"1990","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0800","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2337\/diab.39.12.1569","article-title":"Tumor Necrosis Factor\u2013Increased Hepatic Very-Low-Density Lipoprotein Production and Increased Serum Triglyceride Levels in Diabetic Rats","volume":"39","author":"Feingold","year":"1990","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.bcp.2025.116908_b0805","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b0810","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41577-020-00488-6","article-title":"Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities","volume":"21","author":"Hajishengallis","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2025.116908_b0815","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41423-020-0500-1","article-title":"Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties","volume":"18","author":"Shen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bcp.2025.116908_b0820","doi-asserted-by":"crossref","unstructured":"A. Zaid, K. Tharmarajah, H. Mostafavi, J.R. Freitas, K.C. Sheng, S.S. Foo, W. Chen, J. Vider, X. Liu, N.P. West, L.J. Herrero, A. Taylor, L.K. Mackay, D.R. Getts, N.J.C. King, S. Mahalingam, Modulation of Monocyte-Driven Myositis in Alphavirus Infection Reveals a Role for CX(3)CR1(+) Macrophages in Tissue Repair, mBio 11(2) (2020).","DOI":"10.1128\/mBio.03353-19"},{"key":"10.1016\/j.bcp.2025.116908_b0825","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jdsr.2022.10.002","article-title":"Macrophages in periodontitis: A dynamic shift between tissue destruction and repair","volume":"58","author":"Yin","year":"2022","journal-title":"Jpn Dent Sci Rev"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0830","doi-asserted-by":"crossref","DOI":"10.3390\/md15010007","article-title":"The In Vitro and In Vivo Anti-Inflammatory Effects of a Phthalimide PPAR-gamma Agonist","volume":"15","author":"Su","year":"2017","journal-title":"Mar. Drugs"},{"issue":"8","key":"10.1016\/j.bcp.2025.116908_b0835","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/jcpe.13156","article-title":"Characterization of macrophage polarization in periodontal disease","volume":"46","author":"Garaicoa-Pazmino","year":"2019","journal-title":"J. Clin. Periodontol."},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0840","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jre.12912","article-title":"Hyperglycemia modulates M1\/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis","volume":"56","author":"Zhang","year":"2021","journal-title":"J. Periodontal Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0845","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","volume":"9","author":"Janani","year":"2015","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.bcp.2025.116908_b0850","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.968336","article-title":"Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARgamma\/RXR ligands in IL-4-induced M2a macrophage differentiation","volume":"13","author":"Gopalakrishnan","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b0855","first-page":"454","article-title":"Immunohistochemical and Stereologic Analysis of NF-kappaB Activation in Chronic Periodontitis","volume":"4","author":"Arabaci","year":"2010","journal-title":"Eur J Dent"},{"issue":"8","key":"10.1016\/j.bcp.2025.116908_b0860","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.bcp.2025.116908_b0865","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1073\/pnas.97.9.4844","article-title":"15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway","volume":"97","author":"Straus","year":"2000","journal-title":"PNAS"},{"issue":"6765","key":"10.1016\/j.bcp.2025.116908_b0870","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/47520","article-title":"Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase","volume":"403","author":"Rossi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.116908_b0875","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","article-title":"A paradigm for gene regulation: inflammation, NF-kappaB and PPAR","volume":"544","author":"Vanden Berghe","year":"2003","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"47","key":"10.1016\/j.bcp.2025.116908_b0880","doi-asserted-by":"crossref","first-page":"36703","DOI":"10.1074\/jbc.M004045200","article-title":"Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators","volume":"275","author":"Delerive","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116908_b0885","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56095","article-title":"Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO","volume":"9","author":"Adapala","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2025.116908_b0890","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b0895","article-title":"Effect of Pranayama on Ppar-gamma, Nf-kappaB Expressions and Red Complex Microorganisms in Patients with Chronic Periodontitis - A Clinical Trial","volume":"11","author":"Mahendra","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0900","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2249.2007.03342.x","article-title":"Differential activation of NF-kappaB and gene expression in oral epithelial cells by periodontal pathogens","volume":"148","author":"Milward","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2025.116908_b0905","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0910","doi-asserted-by":"crossref","first-page":"7530","DOI":"10.4049\/jimmunol.172.12.7530","article-title":"Repression of IFN-gamma expression by peroxisome proliferator-activated receptor gamma","volume":"172","author":"Cunard","year":"2004","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b0915","first-page":"4541","article-title":"Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists","volume":"275","author":"Yang","year":"2000","journal-title":"Ppargamma Co-Association with Transcription Factor NFAT, J Biol Chem"},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b0920","first-page":"6503","article-title":"Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10","volume":"164","author":"Marx","year":"2000","journal-title":"Mig, and I-TAC in Human Endothelial Cells, J Immunol"},{"issue":"6742","key":"10.1016\/j.bcp.2025.116908_b0925","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/22572","article-title":"Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12\/15-lipoxygenase","volume":"400","author":"Huang","year":"1999","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2025.116908_b0930","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1210\/me.2004-0529","article-title":"A Nuclear Receptor Atlas: macrophage activation","volume":"19","author":"Barish","year":"2005","journal-title":"Mol. Endocrinol."},{"issue":"6662","key":"10.1016\/j.bcp.2025.116908_b0935","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"issue":"6662","key":"10.1016\/j.bcp.2025.116908_b0940","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2025.116908_b0945","doi-asserted-by":"crossref","DOI":"10.3390\/biom12030373","article-title":"Role of TGF-Beta Signaling in Beta Cell Proliferation and Function in Diabetes","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"issue":"5\u20136","key":"10.1016\/j.bcp.2025.116908_b0950","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/gad.346312.120","article-title":"Chronic tissue inflammation and metabolic disease","volume":"35","author":"Lee","year":"2021","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2025.116908_b0955","article-title":"Aerobic Exercise Improves Pulmonary Fibrosis by Improving Insulin Resistance and Inflammation in Obese Mice","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b0960","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","article-title":"Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma","volume":"93","author":"Nagy","year":"1998","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0965","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"issue":"2 Pt 2","key":"10.1016\/j.bcp.2025.116908_b0970","first-page":"F181","article-title":"Prostanoid biosynthesis and mechanisms of action","volume":"263","author":"Smith","year":"1992","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.bcp.2025.116908_b0975","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.lfs.2016.03.054","article-title":"Implications of the endogenous PPAR-gamma ligand, 15-deoxy-delta-12, 14-prostaglandin J2, in diabetic retinopathy","volume":"153","author":"Behl","year":"2016","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b0980","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0952-3278(92)90178-L","article-title":"Biological activities and mechanisms of action of PGJ2 and related compounds: an update","volume":"47","author":"Fukushima","year":"1992","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b0985","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.116908_b0990","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/rp.56.1.265","article-title":"Insulin resistance and its treatment by thiazolidinediones","volume":"56","author":"Lebovitz","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"issue":"23","key":"10.1016\/j.bcp.2025.116908_b0995","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"S.E. Kahn, S.M. Haffner, M.A. Heise, W.H. Herman, R.R. Holman, N.P. Jones, B.G. Kravitz, J.M. Lachin, M.C. O'Neill, B. Zinman, G. Viberti, A.S. Group","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b1000","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/83336","article-title":"PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation","volume":"7","author":"Chawla","year":"2001","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103059","article-title":"Selective PPARgamma modulator diosmin improves insulin sensitivity and promotes browning of white fat","volume":"299","author":"Yu","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b1010","first-page":"1014","article-title":"Identification of Selective PPAR-gamma Modulators by Combining Pharmacophore Modeling","volume":"195","author":"Li","year":"2023","journal-title":"Molecular Docking, and Adipogenesis Assay, Appl Biochem Biotechnol"},{"key":"10.1016\/j.bcp.2025.116908_b1015","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/103167","article-title":"Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists","volume":"2008","author":"Oleksiewicz","year":"2008","journal-title":"PPAR Res."},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b1020","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.2337\/dc13-2480","article-title":"Can a selective PPARgamma modulator improve glycemic control in patients with type 2 diabetes with fewer side effects compared with pioglitazone?","volume":"37","author":"A.M. DePaoli, L.S. Higgins, R.R. Henry, C. Mantzoros, F.L. Dunn, I.N.T.S. Group","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b1025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1248\/bpb.b20-01002","article-title":"Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor gamma Modulator, in Male Diabetic Mice and Female Ovariectomized Rats","volume":"44","author":"Ito","year":"2021","journal-title":"Biol. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b1030","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.1152\/ajpendo.00569.2011","article-title":"Selective PPARgamma modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice","volume":"302","author":"Lee","year":"2012","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b1035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40265-021-01648-1","article-title":"Chiglitazar: First Approval","volume":"82","author":"Deeks","year":"2022","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b1040","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41598-024-51210-8","article-title":"Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetes","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b1045","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.31843","article-title":"Saroglitazar, a PPAR-alpha\/gamma Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial","volume":"74","author":"Gawrieh","year":"2021","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bcp.2025.116908_b1050","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/apt.16596","article-title":"Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator (SPPARMalpha), versus placebo in patients with non-alcoholic fatty liver disease","volume":"54","author":"Nakajima","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b1055","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/1871530320999200818135553","article-title":"The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase Inhibitors","volume":"21","author":"Kusunoki","year":"2021","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b1060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12933-024-02305-z","article-title":"Lessons from PROMINENT and prospects for pemafibrate","volume":"23","author":"Fruchart","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b1065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14656566.2020.1853100","article-title":"Are thiazolidinediones a preferred drug treatment for type 2 diabetes?","volume":"22","author":"Hurren","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b1070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000353679","article-title":"Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study","volume":"36","author":"Lu","year":"2013","journal-title":"Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b1075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2337\/dc20-0978","article-title":"Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT","volume":"44","author":"Abdul-Ghani","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2025.116908_b1080","series-title":"Thiazolidinediones, StatPearls, Treasure Island (FL) ineligible companies","author":"Eggleton","year":"2023"},{"issue":"12","key":"10.1016\/j.bcp.2025.116908_b1085","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/pds.1804","article-title":"Case series of liver failure associated with rosiglitazone and pioglitazone","volume":"18","author":"Floyd","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"25","key":"10.1016\/j.bcp.2025.116908_b1090","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2174\/092986705774462905","article-title":"PPARs in diseases: control mechanisms of inflammation","volume":"12","author":"Kostadinova","year":"2005","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b1095","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/jre.12754","article-title":"Cinnamic acid decreases periodontal inflammation and alveolar bone loss in experimental periodontitis","volume":"55","author":"Karatas","year":"2020","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.bcp.2025.116908_b1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117738","article-title":"A breakthrough in periodontitis treatment: Revealing the pharmacodynamic substances and mechanisms of Kouqiangjie formula","volume":"323","author":"Wu","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b1105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5051\/jpis.2104060203","article-title":"Effects of aloe-emodin on alveolar bone in Porphyromonas gingivalis-induced periodontitis rat model: a pilot study","volume":"52","author":"Yang","year":"2022","journal-title":"J Periodontal Implant Sci"},{"issue":"1","key":"10.1016\/j.bcp.2025.116908_b1110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/njcp.njcp_349_19","article-title":"PPAR-gamma, RXR, VDR, and COX-2 Expressions in gingival tissue samples of healthy individuals, periodontitis and peri-implantitis patients","volume":"23","author":"Taskan","year":"2020","journal-title":"Niger. J. Clin. Pract."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b1115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/njcp.njcp_216_20","article-title":"Detection of nuclear receptors in gingival samples of diabetic and nondiabetic periodontitis patients","volume":"24","author":"Karatas","year":"2021","journal-title":"Niger. J. Clin. Pract."},{"issue":"10","key":"10.1016\/j.bcp.2025.116908_b1120","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.intimp.2009.06.002","article-title":"PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis","volume":"9","author":"Hassumi","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116908_b1125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2334\/josnusd.20-0010","article-title":"Glucose transporter 4 mediates LPS-induced IL-6 production in osteoblasts under high glucose conditions","volume":"62","author":"Kato","year":"2020","journal-title":"J. Oral Sci."},{"key":"10.1016\/j.bcp.2025.116908_b1130","doi-asserted-by":"crossref","unstructured":"A. Hasankhani, A. Bahrami, B. Tavakoli-Far, S. Iranshahi, F. Ghaemi, M.R. Akbarizadeh, A.H. Amin, B. Abedi Kiasari, A. Mohammadzadeh Shabestari, The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy, Front Immunol 14 (2023) 1127358.","DOI":"10.3389\/fimmu.2023.1127358"},{"issue":"7","key":"10.1016\/j.bcp.2025.116908_b1135","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1007\/s00210-023-02914-7","article-title":"Carvedilol attenuates inflammatory reactions of lipopolysaccharide-stimulated BV2 cells and modulates M1\/M2 polarization of microglia via regulating NLRP3, Notch, and PPAR-gamma signaling pathways","volume":"397","author":"Khoshnavay Foumani","year":"2024","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116908_b1140","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.4049\/jimmunol.1200730","article-title":"Exogenous administration of 15d-PGJ2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model","volume":"189","author":"Napimoga","year":"2012","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2025.116908_b1145","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1210\/endo.140.11.7116","article-title":"Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro","volume":"140","author":"Okazaki","year":"1999","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bcp.2025.116908_b1150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051452","article-title":"PPAR-gamma Agonist GW1929 Targeted to Macrophages with Dendrimer-Graphene Nanostars Reduces Liver Fibrosis and Inflammation","volume":"15","author":"Moreno-Lanceta","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7365","key":"10.1016\/j.bcp.2025.116908_b1155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature10383","article-title":"Antidiabetic actions of a non-agonist PPARgamma ligand blocking Cdk5-mediated phosphorylation","volume":"477","author":"Choi","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b1160","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.bcp.2025.116908_b1165","first-page":"1550","article-title":"A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma","volume":"14","author":"Wang","year":"2000","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116908_b1170","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs","volume":"272","author":"Lehmann","year":"1997","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:51:14Z","timestamp":1778640674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":234,"alternative-id":["S0006295225001704"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116908","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) role in periodontitis and diabetes mellitus: A molecular perspective","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116908"}}